Archive for year: 2020

You are here: Home1 / 2020

Extended PPAS during COVID-19 pandemic

April 27, 2020/in News/by Leandra

https://www.value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Leandra https://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Leandra2020-04-27 12:29:462020-09-21 13:32:40Extended PPAS during COVID-19 pandemic

Headway made for Point Prevalence Audit Survey in primary and long-term care settings

January 10, 2020/in News/by Leandra

https://www.value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Leandra https://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Leandra2020-01-10 14:15:252020-09-21 13:33:05Headway made for Point Prevalence Audit Survey in primary and long-term care settings

Page 2 of 212

Social Media

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 820755. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and bioMérieux SA, Janssen Pharmaceutica NV, Abbott, Bio-Rad Laboratories, BD Switzerland Sàrl, and The Wellcome Trust Limited.

Copyright - Value-Dx - Any dissemination of results must indicate that it reflects only the author's view and that the JUis not responsible for any use that may be made of the information it contains.

Scroll to top

We use cookies to ensure that we can give you the best experience on our website. Accept Refuse Read More